Merck & Dohme v Albrecht (Duty to warn/impossibly doctrine)
Podcast: Supreme Court Decision Syllabus (SCOTUS Podcast)Published On: Tue May 21 2019
Description: Send us a textA clarification on what is considered clear evidence that a drug company could not fulfill it’s duty to warn in light of FDA refusals to allow label changes.
The note was deleted
The note was saved
Your message was sent